MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare MITS vs QlikView

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better MITS or QlikView? If you need to have a easy way to decide which Business Intelligence Software product is better, our proprietary system gives MITS a score of 7.5 and QlikView a score of 9.3 for all round quality and performance. At the same time, MITS is rated at 100%, while QlikView is rated 98% for their user satisfaction level.

You can also examine their product details, including modules, tools, options, plans, prices, and much more. See if the application allows you to customize at least part of its funnels to guarantee the app matches your own business workflows.

We did our best to review all popular Business Intelligence Software solutions offered on the market, but among all the ones we reviewed these three caught our special attention: Sisense, Looker, Sisense for Cloud Data Teams.

If you continue having doubts about which app will work best in your case it might be a sensible idea to examine each service’s social metrics. These metrics are quite often a way to see how popular every software is and how extensive is its online presence. For example, in case of Facebook MITS has 0 likes on their official page while QlikView profile is liked by 28275 users.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.